FY2025 · ended Dec 31, 2025 · Revenue $0 · Filed Mar 26, 2026
Vivani Medical, Inc. (VANI) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $0 and a net loss of $26.6 million. Free cash flow was -$25.5 million. As of Jun 30, 2026 it held $19.9 million in cash and investments and $17.9 million in total debt.
Revenue
$0
Net income
$-26.61M
-13.3% vs prior year
Operating cash flow (TTM)
$-25.30M
-11.3% vs year-ago TTM
Free cash flow (TTM)
$-26.50M
-14.5% vs year-ago TTM
EPS
$-0.43
+0.0% vs prior year
Dividend per share
None
Shares outstanding
84.65M
+42.9% vs prior year
Net cash
$2.04M
as of Jun 30, 2026
Operating margin
-1004.9%
FY 2019
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- VANI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Alameda, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1266806
- Former names
- SECOND SIGHT MEDICAL PRODUCTS INC (until Aug 18, 2022); SECOUND SIGHT MEDICAL PRODUCTS INC (until Oct 10, 2003)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | — | — |
| Operating income | -$27.6M | -$24.7M | -$27.0M | -$21.2M | -$13.3M |
| Net income | -$26.6M | -$23.5M | -$25.7M | -$13.9M | -$12.8M |
| Diluted EPS | -$0.43 | -$0.43 | — | — | — |
| Operating cash flow | -$24.3M | -$20.8M | -$23.7M | -$18.8M | -$11.0M |
| Free cash flow | -$25.5M | -$21.3M | -$24.6M | -$19.1M | -$11.5M |
| Total assets | $39.4M | $41.6M | $45.8M | $51.1M | $5.5M |
| Total liabilities | $23.7M | $24.0M | $25.0M | $6.8M | $3.0M |
| Stockholders' equity | $15.7M | $17.6M | $20.8M | $44.3M | $2.5M |
| Cash and investments | $16.2M | $18.4M | $20.7M | — | $69.6M |
| Total debt | $18.9M | $19.3M | $20.7M | $955,000 | $1.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 30, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 16, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 17, 2026 | Aug 17, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
All 838 Vivani Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.